Ionis Pharmaceuticals (IONS) Other Non Operating Income (2012 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Other Non Operating Income of $987000.0 for Q2 2026, up 867.65% year-over-year from $102000.0 in Q2 2025, and up 316.45% quarter-over-quarter from -$456000.0 in Q1 2026.
Ionis Pharmaceuticals (IONS) Other Non Operating Income (2012 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Other Non Operating Income history runs 12 years deep, the most recent figure standing at $987000.0 for Q2 2026.
- In Q2 2026, Other Non Operating Income rose 867.65% year-over-year to $987000.0; the TTM figure through Jun 2026 stood at $19.2 million (down 63.83% YoY), while the FY2025 annual figure was $19.3 million, down 63.98% from the prior year.
- Other Non Operating Income for Q2 2026 stood at $987000.0, up from -$456000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $53.3 million in Q4 2023, with the low at -$12.3 million in Q2 2022.
- The 5-year median for Other Non Operating Income is $537500.0 (2024), against an average of $10.0 million.
- The sharpest annual moves came in 2022 and 2026: Other Non Operating Income surged 6133.33% in 2022, then plunged 198.06% in 2026.
- Ionis Pharmaceuticals' Other Non Operating Income stood at $47.7 million in 2022, then grew by 11.8% to $53.3 million in 2023, then dropped by 1.51% to $52.5 million in 2024, then slumped by 65.05% to $18.3 million in 2025, then sank by 94.62% to $987000.0 in 2026.
- Business Quant data shows IONS's Other Non Operating Income at $987000.0 in Q2 2026, -$456000.0 in Q1 2026, and $18.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 987,000.00 |
| Mar 31, 2026 | -456,000.00 |
| Dec 31, 2025 | 18.34 Mn |
| Sep 30, 2025 | 363,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 465,000.00 |
| Dec 31, 2024 | 52.47 Mn |
| Sep 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 610,000.00 |
| Mar 31, 2024 | 277,000.00 |
| Dec 31, 2023 | 53.27 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 11.18 Mn |
| Mar 31, 2023 | 230,000.00 |
| Dec 31, 2022 | 47.65 Mn |
| Sep 30, 2022 | 4.71 Mn |
| Jun 30, 2022 | -12.30 Mn |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 32.48 Mn |
| Sep 30, 2021 | -469,000.00 |